medical cannabis
medical cannabis · page 19
- Medical
France’s Medical Cannabis Launch Likely to be Delayed Until 2026
Reported by Newsweed.fr While the French National Agency for the Safety of Medicines (ANSM) assured at the beginning of the year that cannabis-based treatments would be available by 2025, it will be difficult to achieve widespread use of medical cannabis in France before 2026.
- Hemp Industry
Could Pakistan Become the Next Market to Legalise Medical Cannabis?
Pakistan is set to become that latest country to launch a medical cannabis industry, as its National Assembly gets poised to vote through a landmark reform bill.
- Medical
German Doctors May Remain Cautious of Prescribing Medical Cannabis Despite New Rules Opening Up Access For Millions
Last month, Germany’s Federal Joint Committee (G-BA) proposed significant changes to the medical cannabis prescription process, opening the door for medical cannabis to be prescribed via statutory health insurance (gesetzliche Krankenversicherung or GKV) This would enable around 70% of practicing German physicians to prescribe medical cannabis without prior approval from health insurance companies, which would…
- Medical
Calls to Restrict Medical Cannabis Prescriptions in Germany Grow as the Flourishing Market Shows No Signs of Slowing Down
Medical cannabis prescriptions have exploded across Germany since April 01 when its landmark CanG Act was brought into force.
- Uncategorized
Leafwell Research: Anxiety Tops List for Young Medical Cannabis Patients in US
A comprehensive study conducted by Leafwell offers a deep dive into the medical cannabis usage patterns among individuals under the age of 21 in the United States, a demographic that has been largely under-researched.
- Press releases
Dalgety Secures EU-GMP Certification and Upgraded Home Office License
Dalgety has become one of two leading medical cannabis cultivators in the UK to be granted a Home Office licence to supply in the UK alongside a full EU-GMP certification.
- Opinion
Why the UK Needs to Fund Research on Medical Cannabis and ADHD
Written for Business of Cannabis by Iqra Arif MPharm at Wellford Medical Clinic Understanding ADHD Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that impacts both children and adults.
- Medical
Ukraine Legalises Medical Cannabis, But PTSD Currently Omitted From Official List of Conditions
Last week, Ukraine’s law officially legalising medical cannabis came into effect, eight months after initially being passed.
- Adult-Use
Italy Looks to EC to Save Its Hemp Industry, Poland Clamps Down on Cannabis Prescriptions, & Norway Launches Legalisation Initiative
Italy’s Hemp Industry Hopes the EU Will Save it From Government Bill The Italian hemp industry is mounting a defense against the Meloni government’s escalating efforts to criminalise light cannabis, including CBD products, amid fears that these measures could violate European Union regulations and devastate the sector.
- Medical
Medical Cannabis in the UK: Best Practice Guidelines Urged Amid Growing Regulatory Scrutiny
As reported by Cannabis Health As the UK medical cannabis industry reaches a ‘tipping point’, experts are urging clinics to follow best practice guidelines, as regulators look to crackdown on what has been described as a ‘pseudo-recreational market’.
- Uncategorized
New Legislation Expands Who Can Prescribe and Qualify for Medical Cannabis in New Hampshire
New Hampshire has significantly expanded its medical cannabis program, enacting two separate bills removing restrictions on which conditions cannabis can be prescribed for and which medical professionals can issue prescriptions.
- Medical
Germany’s Medical Cannabis Imports Soar Post-CanG: Q2 Data Reveals 44% Spike
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has published the medical cannabis import figures for Q2, giving us the first concrete data on the impact its pioneering cannabis reforms have had on the market.
